Clinical-stage biopharmaceutical company
2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about GH Research PLC.
The 1 sources with the most insights about GH Research PLC on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Developing proprietary DMT-based therapies for treatment-resistant depression with promising clinical upside.
Bullish sentiment; mentioned as a stock the speaker is 'long'.
Developing proprietary DMT-based therapies for treatment-resistant depression with promising clinical upside.
Bullish sentiment; mentioned as a stock the speaker is 'long'.
Other assets that creators frequently mention in the same content as GH Research PLC.
The most active sources covering GH Research PLC (GHRS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about GH Research PLC (GHRS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering GH Research PLC (GHRS) most frequently also discuss SPRB, COHR, AMZN, IONQ, FN. See the "Discussed alongside" section above for full asset pages.